Back to Search
DR. GAURAB BASU MD
MD
Internal Medicine Physician
NPI: 1538488812IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
255713(MA)
Education
UNIVERSITY OF VERMONT COLLEGE OF MEDICINE
Class of 2010
Research & Publications (20)
Functional evidence implicating S100P in prostate cancer progression.
PMID 18452169·Int J Cancer·2008
7-preclinical
Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO.
PMID 16888001·J Immunol·2006
7-preclinical
A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells.
PMID 17156488·Breast Cancer Res·2006
7-preclinical
Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
PMID 15987447·Breast Cancer Res·2005
7-preclinical
Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer.
PMID 15561779·Mol Cancer Res·2004
7-preclinical
Electrostatic potential of nucleotide-free protein is sufficient for discrimination between adenine and guanine-specific binding sites.
PMID 15342256·J Mol Biol·2004
8-other
Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition.
PMID 19109152·J Immunol·2009
7-preclinical
A chimaeric glutamyl:glutaminyl-tRNA synthetase: implications for evolution.
PMID 18817520·Biochem J·2009
8-other
Coulomb energies of protein-protein complexes with monopole-free charge distributions.
PMID 19167253·J Mol Graph Model·2009
8-other
Status of groundwater arsenic contamination in the state of West Bengal, India: a 20-year study report.
PMID 19382148·Mol Nutr Food Res·2009
8-other
The role of the catalytic domain of E. coli GluRS in tRNAGln discrimination.
PMID 19481543·FEBS Lett·2009
8-other
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer.
PMID 19519883·J Transl Med·2009
8-other
Conformational preferences of a short Aib/Ala-based water-soluble peptide as a function of temperature.
PMID 19137603·Proteins·2009
8-other
A model for human leukocyte antigen-matched donor-swap transplantation in India.
PMID 18337661·Transplantation·2008
8-other
MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.
PMID 18713982·J Immunol·2008
7-preclinical
Enhanced stability of cis Pro-Pro peptide bond in Pro-Pro-Phe sequence motif.
PMID 17765893·FEBS Lett·2007
8-other
Differential colchicine-binding across eukaryotic families: the role of highly conserved Pro268beta and Ala248beta residues in animal tubulin.
PMID 17927988·FEBS Lett·2007
7-preclinical
Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification.
PMID 17332321·Cancer Res·2007
8-other
MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model.
PMID 17166639·Vaccine·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 75 FRANCIS ST
BOSTON, MA 02115 - Phone
- (617) 732-6040
Quick Facts
- NPI
- 1538488812
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile